论文部分内容阅读
国际动脉粥样硬化学会(IAS)颁布了《血脂异常管理的全球推荐》(以下简称《推荐》),旨在降低动脉粥样硬化性心血管疾病(ASCVD)的发生风险。主要更新如下:1.终身预防的观念:血脂管理要有更长远的规划,要将风险的评估推算到个人80岁时发生心血管事件的风险,强调终身预防的观念。2.选择血脂管理主要目标的观念:会导致动脉硬化的脂蛋白不只是LDL-C,计算Non-HDL-C更能代表所有能造成动脉硬化的脂蛋白,包括富含胆固醇的VLDL残片等,所以在血
The International Society of Atherosclerosis (IAS) has issued the Global Recommendations for the Management of Dyslipidemias (hereinafter referred to as “Recommended”) to reduce the risk of developing atherosclerotic cardiovascular disease (ASCVD). The main updates are as follows: 1. The concept of lifelong prevention: blood lipid management to have more long-term planning, risk assessment should be calculated to 80 individuals at the risk of cardiovascular events, emphasizing the concept of lifelong prevention. 2. Select the main goal of lipid management concept: will lead to atherosclerosis not only LDL-C lipoprotein, non-HDL-C is more representative of all can cause atherosclerosis lipoprotein, including cholesterol-rich VLDL fragments, etc., So in the blood